Altogether, butyrate may counteract obesity‐associated mitochondrial dysfunction and muscle atrophy and can indirectly increase insulin‐mediated glucose disposal in the muscle tissue. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.